GZD824
GZD824 is a novel orally bioavailable Bcr-Abl inhibitor for Bcr-Abl(WT) and Bcr-Abl(T315I) with IC₅₀ of 0.34 nM and 0.68 nM, respectively.
Product Specifications
Shipping Conditions
Gel Pack
Storage Conditions
-20°C
Shelf Life
36 months
More Discoveries
Explore Other Products
Browse additional items from our catalog
K3014504 1.0 µg DNA
Pira4 sgRNA CRISPR Lentivector (Mouse) (Target 3)
Sign In for Pricing
View Details 
